|
National Stock Number(NSN): 6505-00-238-5222 (6505002385222, 002385222)
| NIIN: |
00-238-5222 |
Item Name: |
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION |
INC: |
34459
|
| FSC: |
6505
|
Assignment Date: |
Nov-06-1970 |
CRIT: |
X |
IIG: |
34459 |
| ISC: |
5 |
Date Standardized: |
Feb-01-1975 |
HMIC: |
P |
DODIC: |
|
| NSC: |
0 |
Cancellation Date: |
|
PMIC: |
A |
FIIG: |
A34300 |
| ESD: |
|
Schedule B: |
2937.21.0000 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
98 |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
111-08 |
60567
|
LYPHOMED INC DIV OF FUJISAWA USA INC |
C |
5 |
9 |
6 |
54 |
|
B |
|
|
|
|
|
A-HYDROCORT UNIVIAL |
70048
|
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV |
C |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
NDC00009-0920-01 |
93703
|
PHARMACIA & UPJOHN COMPANY |
C |
3 |
2 |
6 |
54 |
|
|
|
|
|
|
|
NDC00074-5674-08 |
70048
|
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV |
C |
3 |
2 |
4 |
KX |
|
|
|
|
|
|
|
NDC00469-1110-08 |
60567
|
LYPHOMED INC DIV OF FUJISAWA USA INC |
C |
5 |
9 |
6 |
54 |
|
B |
|
|
|
|
|
SOLU-CORTEF MIX-O-VIAL |
93703
|
PHARMACIA & UPJOHN COMPANY |
C |
5 |
1 |
6 |
54 |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DF |
JDC |
L |
|
Q |
U |
1 |
F |
$24.72 |
VI |
|
------N |
Jan-01-1988 |
H |
| DN |
S9M |
V |
|
Q |
U |
1 |
N |
$24.72 |
VI |
|
9L----- |
Jun-01-1994 |
H |
| VA |
G36 |
G |
|
Q |
U |
0 |
V |
$6.59 |
VI |
|
------- |
May-01-1989 |
C |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DF |
R |
REFER TO NON-STD NON-DMSB REV |
000 |
|
|
|
| DN |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| VA |
K |
U/I CONTAINS 8 ML |
000 |
|
|
|
| VA |
R |
REFER TO NOT YET AVAIL |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AGXW |
PHYSICAL FORM |
POWDER |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
1000.000 MILLIGRAMS HYDROCORTISONE EQUIVALENT |
| CBBL |
FEATURES PROVIDED |
THINNER |
| CQCT |
PRIMARY CONTAINER TYPE |
VIAL |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
8.000 MILLILITERS AFTER RECONSTITUTION |
| CSGS |
ADMINISTRATION |
INTRAMUSCULAR OR INTRAVENOUS |
| FEAT |
SPECIAL FEATURES |
EACH WHEN MIXED CONTAINS 8 MG MONOBASIC SODIUM PHOSPHATE ANHYDROUS; 88 MG DIBASIC SODIUM PHOSPHATE DRIED AND 66.9 OR 72 MG BENZYL ALCOHOL AS PRESERVATIVE; 2 COMPARTMENT VIAL |
| MDES |
MEDICAL DESIGNATION AND GRADE |
UNITED STATES PHARMACOPEIA |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| V542 |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54 |
| Source: |
A |
Packaging Data Record contains data that does not meet current MIL-STD-2073-1C/D formats |
Status: |
C |
| Pri/Sec ICC: |
P |
Container NSN: |
|
Category Code: |
|
| Lvl A Pkg Req: |
|
Unit Pack Size: |
|
Pres Material: |
ZZ |
| Lvl B Pkg Req: |
|
Unit Pack Weight: |
0.1 |
Pres Method: |
ZZ |
| Lvl C Pkg Req: |
|
Unit Pack Cube: |
0.011 |
Wrapping Mat: |
ZZ |
| Opt Proc Ind: |
|
Unpkg Item Dims: |
|
Spec Marking: |
|
| Container FSC: |
|
SPI Number: |
|
SPI Revision: |
|
| Unpkg Weight: |
|
SPI Date: |
|
Pkg Design Activity: |
|
| Inter Container Qty: |
|
Inter Container Code: |
ZZ |
Clean/Dry Procedure: |
Z |
| Unit Container: |
ZZ |
Item Type Storage: |
|
Unit Container Level: |
|
| |
|
Cush/Dun Material: |
ZZ |
Cush/Dun Thickness: |
Z |
|